Filing Details

Accession Number:
0001929354-23-000012
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-02 16:22:32
Reporting Period:
2023-05-31
Accepted Time:
2023-06-02 16:22:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1534120 Avalo Therapeutics Inc. AVTX Pharmaceutical Preparations (2834) 450705648
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1929354 Ltd. Management Capital Caissa Palm Grove House
Wickhams Cay 1 Road Town
Tortola D8 VG1110
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-05-31 844 $2.87 1,386,215 No 4 P Indirect See Footnote (1)
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote (1)
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 182,300 Direct
Footnotes
  1. Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh.
  2. These shares are directly owned by Mr. Golestaneh in his personal capacity.